Company: NTCL
Filing Date: 2025-10-20
Form Type: F-1
Source: 0001104659-25-100526
Chunk: 211

Company: NetClass Technology Inc
Filing Date: 2025-10-20
Form: F-1
Chunk 211
---
 of Compensation Committee

Xiao Fu is our independent director. Mr. Fu has more than 10 years of rich experience in equity investment and fund management. He has been the general manager of Shanghai Rizhen Private Equity Fund Management Co., Ltd since January 2012, he is responsible for the daily overall management of the company. From September 2002 to January 2012, Mr. Xiao Fu served as the director of industry consulting department in eastern mainland China and director of industry consulting department in Shanghai of Kingdee software (China) Co., Ltd, a subsidiary of a publicly traded company, Kingdee International Software Group Co., Ltd (HKEX: 00268) and his responsibility is expansion and management of the consulting business in Shanghai and eastern mainland China. Mr. Xiao Fu is the invited lecturer of the MBA Education Center of East China Normal University and invited lecturer of Shanghai University of Finance and Economics since 2015, and an entrepreneurial tutor of Shanghai University of Political Science and Law since 2016, a member of

<div align='center'>109</div>

Chinese Association for Artificial Intelligence since 2019, and he is the council member of Shanghai IT Youth Talent Association since 2016.

Mr. Xiao Fu received a Bachelor Degree of Computer Application from the School of Computer Engineering and Science of Shanghai University in 1997, and received Master Degree of Computer Application from the School of Computer Engineering and Science of Shanghai University in 2000.

Family Relationships

None of the directors or executive officers has a family relationship as defined in Item 401 of Regulation S-K.

Involvement in Certain Legal Proceedings

To the best of our knowledge, except as otherwise described below, none of our directors or executive officers has, during the past 10 years, been involved in any legal proceedings described in subparagraph (f) of Item 401 of Regulation S-K.

Our Chief Executive Officer, Chairman of the Board and Director, Dr. Jianbiao Dai has been named in an arbitration application initiated in June 2022 by a shareholder of an entity (the “Applicant”) against certain parties related to such entity. Dr. Dai is a 2% shareholder of such entity. The Applicant is seeking to hold Dr. Dai personally responsible for a portion of such entity’s underperformance in the amount of RMB 39.23 million (approximately USD $5.4 million) plus any unpaid interest accrued until the date of payment (as of June 22, 2022, the accrued but unpaid interest in the amount of